The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
2009

Predicting Outcomes in Laryngeal Cancer with p53, PCNA, and Ki-67

Sample size: 71 publication Evidence: moderate

Author Information

Author(s): Sarafoleanu D, Postelnicu V, Iosif C, Manea C, Sarafoleanu C

Primary Institution: ‘Sfanta Maria’ Clinical Hospital, ENT–HNS Department, Bucharest, Romania

Hypothesis

The study aims to determine the importance of p53, PCNA, and Ki-67 as outcome predictors in laryngeal carcinoma treatment.

Conclusion

The study found that high levels of p53, PCNA, and Ki-67 are correlated with poor differentiation and worse survival outcomes in laryngeal cancer patients.

Supporting Evidence

  • High values of p53, PCNA, and Ki-67 are associated with poor differentiation in laryngeal carcinomas.
  • Patients with well-differentiated tumors had a survival rate of 90%.
  • Patients diagnosed in advanced TNM stages had lower survival rates.

Takeaway

Doctors can use certain markers in laryngeal cancer to predict how well a patient will do after treatment.

Methodology

A retrospective study analyzing immunohistochemical markers in 71 patients with laryngeal carcinoma who underwent surgery.

Limitations

The study is limited to a retrospective analysis and may not account for all variables affecting outcomes.

Participant Demographics

Patients aged 35 to 71, with 90.1% being men.

Statistical Information

P-Value

p<0.001

Confidence Interval

95%

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication